Baillie Gifford & CO Ionis Pharmaceuticals Inc Transaction History

Baillie Gifford & CO

$131 Billion
Q3 2024

A detailed history of Baillie Gifford & CO transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Baillie Gifford & CO holds 39,581 shares of IONS stock, worth $1.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,581

Previous 260,254 84.79%

Holding current value

$1.38 Million

Previous $12.4 Million 87.22%

% of portfolio

0.0%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$40.06 - $51.86 $8.84 Million - $11.4 Million	-220,673 Reduced 84.79%	39,581 $1.59 Million
Q2 2024 Jul 25, 2024	SELL	$36.45 - $47.7 $1.29 Million - $1.69 Million	-35,429 Reduced 11.98%	260,254 $12.4 Million
Q1 2024 May 01, 2024	SELL	$42.03 - $53.55 $117,684 - $149,940	-2,800 Reduced 0.94%	295,683 $12.8 Million
Q4 2023 Jan 26, 2024	SELL	$43.39 - $51.63 $787,354 - $936,877	-18,146 Reduced 5.73%	298,483 $15.1 Million
Q3 2023 Nov 13, 2023	SELL	$38.5 - $47.13 $528,104 - $646,482	-13,717 Reduced 4.15%	316,629 $14.4 Million
Q2 2023 Jul 28, 2023	SELL	$34.73 - $43.33 $80,330 - $100,222	-2,313 Reduced 0.7%	330,346 $13.6 Million
Q1 2023 May 03, 2023	SELL	$33.58 - $41.2 $37,911 - $46,514	-1,129 Reduced 0.34%	332,659 $11.9 Million
Q4 2022 Jan 24, 2023	BUY	$37.12 - $46.52 $332,075 - $416,167	8,946 Added 2.75%	333,788 $12.6 Million
Q3 2022 Oct 27, 2022	BUY	$36.54 - $48.66 $505,238 - $672,821	13,827 Added 4.45%	324,842 $14.4 Million
Q2 2022 Aug 08, 2022	SELL	$31.71 - $43.0 $1.2 Million - $1.63 Million	-37,848 Reduced 10.85%	311,015 $11.5 Million
Q1 2022 May 05, 2022	BUY	$29.88 - $37.04 $987,324 - $1.22 Million	33,043 Added 10.46%	348,863 $12.9 Million
Q4 2021 Jan 20, 2022	BUY	$25.61 - $35.1 $353,853 - $484,976	13,817 Added 4.58%	315,820 $9.61 Million
Q3 2021 Oct 19, 2021	BUY	$33.54 - $40.55 $1.03 Million - $1.24 Million	30,607 Added 11.28%	302,003 $10.1 Million
Q2 2021 Aug 02, 2021	BUY	$34.54 - $47.25 $1.15 Million - $1.58 Million	33,437 Added 14.05%	271,396 $10.8 Million
Q1 2021 May 06, 2021	BUY	$42.51 - $63.78 $4.75 Million - $7.13 Million	111,741 Added 88.53%	237,959 $10.7 Million
Q4 2020 Feb 10, 2021	SELL	$45.3 - $60.27 $217 Million - $289 Million	-4,794,625 Reduced 97.44%	126,218 $7.14 Million
Q3 2020 Nov 12, 2020	SELL	$47.45 - $62.95 $156 Million - $208 Million	-3,297,856 Reduced 40.13%	4,920,843 $233 Million
Q2 2020 Aug 12, 2020	SELL	$46.85 - $61.05 $24.7 Million - $32.2 Million	-526,984 Reduced 6.03%	8,218,699 $485 Million
Q1 2020 May 08, 2020	SELL	$41.6 - $63.4 $1.84 Million - $2.81 Million	-44,342 Reduced 0.5%	8,745,683 $413 Million
Q4 2019 Feb 10, 2020	BUY	$53.85 - $65.27 $20.2 Million - $24.5 Million	374,736 Added 4.45%	8,790,025 $531 Million
Q3 2019 Nov 07, 2019	SELL	$59.06 - $72.15 $1.71 Million - $2.09 Million	-28,960 Reduced 0.34%	8,415,289 $504 Million
Q2 2019 Aug 08, 2019	SELL	$62.09 - $86.14 $12.4 Million - $17.2 Million	-200,102 Reduced 2.31%	8,444,249 $543 Million
Q1 2019 May 01, 2019	SELL	$52.92 - $81.17 $5.59 Million - $8.58 Million	-105,663 Reduced 1.21%	8,644,351 $0
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $9.03 Million - $12.4 Million	-208,099 Reduced 2.32%	8,750,014 $473 Million
Q3 2018 Nov 13, 2018	SELL	$42.88 - $53.7 $13.8 Million - $17.3 Million	-321,617 Reduced 3.47%	8,958,113 $462 Million
Q2 2018 Jul 17, 2018	BUY	$40.53 - $50.7 $122 Million - $153 Million	3,017,079 Added 48.18%	9,279,730 $387 Million
Q1 2018 May 10, 2018	SELL	$44.08 - $55.05 $15.4 Million - $19.2 Million	-349,650 Reduced 5.29%	6,262,651 $276 Million
Q4 2017 Feb 13, 2018	SELL	$50.3 - $64.39 $17.9 Million - $22.9 Million	-355,848 Reduced 5.11%	6,612,301 $333 Million
Q3 2017 Oct 20, 2017	SELL	$45.56 - $59.57 $21.9 Million - $28.6 Million	-480,231 Reduced 6.45%	6,968,149 $353 Million
Q2 2017 Aug 10, 2017	BUY	N/A	7,448,380	7,448,380 $379 Million

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.96B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.

Account

Baillie Gifford & CO Ionis Pharmaceuticals Inc Transaction History